3 Stocks I’d Avoid at All Costs

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is one stock I’d avoid at all costs. Two others also make the list.

| More on:
Bad apple with good apples

Image source: Getty Images

In today’s market, a clear separation of winners and losers is emerging. In the early months of the COVID-19 pandemic, stocks fell in unison, as investors scrambled to make sense of the pandemic’s effects on corporate earnings. Today, things are more differentiated. Tech stocks are positive for the year, while airlines and energy stocks remain in the gutter. In this environment, you have to be careful what you buy. With that in mind, here are three stocks I’d avoid at all costs.

Air Canada

Air Canada (TSX:AC) is a stock I’ve covered extensively in the past. The financial issues it’s experiencing this year are too numerous to list. Some highlights include $2.75 billion in year-to-date losses, an 89% revenue decline, and surging interest expenses. Theoretically, Air Canada’s business should be able to turn around. All it has to do is get its passenger volume up to where it was before to become profitable again. The problem is that people are still avoiding air travel. As recently as September, Air Canada was actively cutting routes. Even with the economy partially opened, individuals are still avoiding flying. So, there’s no clear path to recovery for this company.

Baytex Energy

Baytex Energy (TSX:BTE)(NYSE:BTE) is a debt-addled energy stock that has been in a freefall for years. Having peaked at $58.55 in 2011, it’s down 99.22% since then. This year, things are going pretty badly for the company. It earned $0.03 per share in the second quarter, but lost $4.46 in the first. That leaves it with squarely negative earnings for the year. The company has always struggled with debt, which remains at about $2 billion. The $28 million in quarterly interest expenses on that debt makes turning a profit difficult. Overall, this stock is a long-term loser that could go lower still.

Aurora Cannabis

Aurora Cannabis (TSX:ACB)(NYSE:ACB) was once a darling of the cannabis space, but its best days appear to be behind it. The company is trying hard to get its expenses under control, but that didn’t prevent it from incurring a massive $1.86 billion loss in Q4. To be fair, that loss was mostly impairment. If we use a cash flow metric, the situation gets better, but it’s still not great. Net cash used in operating activities was $64 million, worse than the same quarter a year before. For the full year, gross profit was negative to the tune of $33 million, down from a $142 million profit a year before.

What we see here is a company that’s really struggling to turn a profit, even when it’s deliberately trying to lower expenses. Unfortunately, it’s in a tough place. In order to turn a profit any time soon, it needs to reduce its costs. But that impedes its ability to fuel growth. Previously, this company was growing revenue at over 100% year over year. That’s slowed right down, and the company has nowhere left to go.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Hexo Stock Jumps 10% on Definitive Tilray Deal

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock jumped 10% on Monday, as its deal with Tilray (TSX:TLRY)(NASDAQ:TLRY) stock became official.

Read more »

edit Jars of marijuana
Cannabis Stocks

Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Tilray Stock Rallied After its Q3 Results

Here's why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Tuesday, March 29

TSX investors may want to keep an eye on the latest consumer confidence and job openings data from the U.S.…

Read more »